We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$304B
AUM Growth
-$14.5B
Cap. Flow
-$11.3B
Cap. Flow %
-3.72%
Top 10 Hldgs %
15.32%
Holding
7,717
New
593
Increased
2,914
Reduced
3,244
Closed
656

Sector Composition

Rank Sector Weight
1 Financials 8.59%
2 Technology 8.45%
3 Healthcare 7.6%
4 Consumer Discretionary 6.86%
5 Energy 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMI
7326
CALL
DELISTED
Foundation Medicine, Inc.
FMI
-48,600
Closed -$1.02M
FMI
7327
PUT
DELISTED
Foundation Medicine, Inc.
FMI
-48,600
Closed -$1.02M
IMNP
7328
DELISTED
Immune Pharmaceuticals Inc.
IMNP
-1,692
Closed -$25K
JASO
7329
PUT
DELISTED
JA Solar Holdings, Co., Ltd
JASO
-7,600
Closed -$74K
YGE
7330
CALL
DELISTED
Yingli Green Energy Holding Comp
YGE
-1,920
Closed -$9K
YGE
7331
DELISTED
Yingli Green Energy Holding Comp
YGE
-29,992
Closed -$136K
YGE
7332
PUT
DELISTED
Yingli Green Energy Holding Comp
YGE
-950
Closed -$4K
ANTH
7333
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-25,000
Closed -$928K
ANTH
7334
PUT
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-25,000
Closed -$928K
FINL
7335
PUT
DELISTED
Finish Line
FINL
-7,900
Closed -$143K
AEUA
7336
DELISTED
Anadarko Petroleum Corporation
AEUA
-231,449
Closed -$7.86M
SEA
7337
DELISTED
Invesco Shipping ETF
SEA
-35,181
Closed -$446K
AHGP
7338
DELISTED
Alliance Holdings GP
AHGP
-469,326
Closed -$9.47M
OAKS
7339
DELISTED
Five Oaks Investment Corp.
OAKS
-11,800
Closed -$64K
ACFC
7340
DELISTED
Atlantic Coast Financial Corporation
ACFC
-15,816
Closed -$93K
EVEP
7341
CALL
DELISTED
EV Energy Partners, L.P.
EVEP
-2,700
Closed -$8K
IPXL
7342
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
-50,000
Closed -$2.14M
IPXL
7343
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
-50,000
Closed -$2.14M
NRCIB
7344
DELISTED
National Research Corp Class B
NRCIB
-8,058
Closed -$289K
SGG
7345
DELISTED
iPath Bloomberg Sugar Subindex Total Return ETN due June 24, 2038
SGG
-30,464
Closed -$1.06M
STRP
7346
DELISTED
Straight Path Communications Inc.
STRP
-16,112
Closed -$276K
CAA
7347
PUT
DELISTED
CalAtlantic Group, Inc.
CAA
-18,483
Closed -$701K
WAC
7348
PUT
DELISTED
Walter Investment Mgt Corp
WAC
-5,600
Closed -$80K
SYT
7349
CALL
DELISTED
Syngenta Ag
SYT
-10,000
Closed -$787K
RIC
7350
DELISTED
Richmont Mines Inc.
RIC
-34,399
Closed -$110K

Similar funds

Goldman Sachs's Q1 2016 Portfolio in Review

As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.

  • Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
  • Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
  • Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
  • Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
  • Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
  • Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
  • Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.